Alyeska Investment Group, L.P. - MARAVAI LIFESCIENCES HLDGS I ownership

MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of MARAVAI LIFESCIENCES HLDGS I
ValueSharesWeighting
Q3 2023$23,857,470
-22.5%
2,385,747
-3.6%
0.16%
-29.3%
Q2 2023$30,773,535
+23.1%
2,475,747
+38.8%
0.23%
+4.6%
Q1 2023$24,994,695
+39.9%
1,784,061
+42.9%
0.22%
+18.4%
Q4 2022$17,870,600
-56.5%
1,248,819
-22.4%
0.18%
-61.4%
Q3 2022$41,092,000
+41.3%
1,609,572
+57.3%
0.48%
+43.8%
Q2 2022$29,079,000
-5.9%
1,023,531
+16.8%
0.33%
-2.3%
Q1 2022$30,902,000
+43.1%
876,147
+99.1%
0.34%
+27.7%
Q3 2021$21,597,000
+389.6%
440,046
+255.6%
0.27%
+368.4%
Q1 2021$4,411,000
-85.2%
123,764
-88.3%
0.06%
-86.4%
Q4 2020$29,744,0001,060,4080.42%
Other shareholders
MARAVAI LIFESCIENCES HLDGS I shareholders Q1 2023
NameSharesValueWeighting ↓
GTCR LLC 21,681,033$1,064,105,00026.99%
Ghisallo Capital Management LLC 1,250,000$61,350,0002.33%
Beck Bode, LLC 160,064$7,856,0002.19%
Select Equity Group, L.P. 12,122,011$594,948,300,0002.00%
Pinz Capital Management, LP 83,603$4,103,0001.86%
Monashee Investment Management LLC 185,000$9,080,0001.68%
Ownership Capital B.V. 2,717,559$133,378,0001.51%
Eversept Partners, LP 327,810$16,088,9151.12%
Parkman Healthcare Partners LLC 90,000$4,417,0001.12%
Connacht Asset Management LP 28,569$1,402,0000.91%
View complete list of MARAVAI LIFESCIENCES HLDGS I shareholders